Novartis - the Swiss pharmaceutical company, one of the largest in the world - will produce the vaccine for COVID-19, developed by the German company CureVac. The agreement signed by the companies calls for the production of tens of millions of doses of the vaccine by the end of 2021. The work on the CureVac vaccine is supervised by a Pole - Dr. Mariola Fotin-Mleczek.